- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
6986
TWO
Week ended 14 Aug 2026
Weekly Investor Report
HeXun Biosciences Co., Ltd. · Healthcare · Biotechnology
Latest close
43.10 TWD
-2.3%
latest week
Weekly setup
Weak trend
The weekly trend is not active. Price is -22.8% below the Trend Line and sits at 1.7% of its 52-week range. The latest completed week returned -2.3%, after a -4.8% four-week move. Near-term considerations: volume confirmation is below normal.
Setup score
16
out of 100
Latest Close
43.10 TWD
14 Aug 2026
1W Return
-2.3%
latest completed week
4W Return
-4.8%
short-term follow-through
12W Return
-27.9%
quarterly tape
Trend Breadth
15.4%
8 of 52 weeks active
Volume Ratio
0.3x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
-2.3%
Latest completed week; four-week move -4.8%.
Indicator stack
8/23
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 37.11%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -22.8% below the Trend Line and sits at 1.7% of its 52-week range. The latest completed week returned -2.3%, after a -4.8% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.3x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
14 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0512-week average 0.26
12-week confirmation
Trend active3/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.05Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is -4.8% over four weeks, -27.9% over 12 weeks, and -35.0% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year8
Trend breadth15.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-1.35Latest activity-pressure read.
Pressure change-31.6%Four-week change in activity pressure.
Leadership-48.31Latest relative-leadership reading.
RS change-4.7%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment-
No current sentiment snapshot is stored.
Patient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-40.1%Distance below the 52-week high.
13-week volatility5.3%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
20 Mar
17 Apr
15 May
12 Jun
10 Jul
14 Aug
Weeks higher8 of 2618 weeks finished lower.
Best week+11.1%Week of 20 Mar.
Worst week-15.0%Week of 26 Jun.
Latest week-2.3%Week of 14 Aug.
Shape of recent returns
Strong gains5
Modest gains3
Flat weeks0
Modest losses11
Sharp losses7
Recent vol5.3%13-week weekly-return volatility.
Base vol5.4%52-week weekly-return volatility.
Up/down split14/37Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -3.3%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorTW Healthcare
4-week rank- / 100
Group average0.1%
Trend breadth34.0%
Trend34.0%active weekly trend signals
MD60.0%positive activity pressure
RS9.0%positive relative leadership
Four-week leaders
IndustryTW Biotechnology
4-week rank62 / 96
Group average-2.7%
Trend breadth24.0%
Trend24.0%active weekly trend signals
MD39.6%positive activity pressure
RS6.2%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape16/100
Trend, activity pressure, participation, and risk combine to a 16/100 tape read.
Indicator analysis24/100Latest 12-week confirmation: trend 3/12, activity pressure 5/12, relative leadership 0/12.
Activity pressure 0.05; No reversal markers Next-Week ExpectancyNegative 37.11%Next-week expectancy is negative with a 37.11% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100No sentiment snapshot is stored yet.
Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 14 Aug 2026 | 43.10 TWD | -2.3% | 55.80 TWD | 65.50 TWD | -1.35 | -48.31 | 237.0K | Off |
| 7 Aug 2026 | 44.10 TWD | -0.9% | 56.42 TWD | 65.66 TWD | -1.40 | -46.24 | 338.0K | Off |
| 31 Jul 2026 | 44.50 TWD | -0.8% | 57.05 TWD | 65.82 TWD | -1.36 | -45.47 | 454.0K | Off |
| 24 Jul 2026 | 44.85 TWD | -0.9% | 57.85 TWD | 65.97 TWD | -1.20 | -46.77 | 291.0K | Off |
| 17 Jul 2026 | 45.25 TWD | -3.7% | 58.63 TWD | 66.13 TWD | -1.03 | -46.13 | 482.0K | Off |
| 10 Jul 2026 | 47.00 TWD | -7.1% | 59.15 TWD | 66.28 TWD | -0.61 | -48.41 | 971.4K | Off |
| 3 Jul 2026 | 50.60 TWD | 5.4% | 59.44 TWD | 66.43 TWD | -0.07 | -47.27 | 2.0M | Off |
| 26 Jun 2026 | 48.00 TWD | -15.0% | 59.65 TWD | 66.54 TWD | 0.28 | -48.57 | 2.5M | Off |
| 19 Jun 2026 | 56.50 TWD | -6.1% | 59.87 TWD | 66.68 TWD | 0.77 | -43.10 | 729.1K | Off |
| 12 Jun 2026 | 60.20 TWD | -1.6% | 59.97 TWD | 66.76 TWD | 0.84 | -37.46 | 687.8K | On |
| 5 Jun 2026 | 61.20 TWD | -4.5% | 59.70 TWD | 66.81 TWD | 0.75 | -38.77 | 305.6K | On |
| 29 May 2026 | 64.10 TWD | 7.2% | 59.57 TWD | 66.86 TWD | 0.78 | -36.50 | 529.9K | On |
| 22 May 2026 | 59.80 TWD | -0.5% | 59.35 TWD | 66.88 TWD | 0.65 | -38.28 | 240.1K | On |
| 15 May 2026 | 60.10 TWD | -2.8% | 59.29 TWD | 66.93 TWD | 0.82 | -37.38 | 349.8K | On |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.